Brooks Moore & Associates’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.74M | Buy |
34,417
+2,591
| +8% | +$604K | 3.92% | 2 |
|
|
2026
Q1 | $7.78M | Sell |
31,826
-3,241
| -9% | -$755K | 3.9% | 2 |
|
|
2025
Q4 | $7.26M | Sell |
35,067
-171
| -0.5% | -$33.8K | 3.57% | 5 |
|
|
2025
Q3 | $6.53M | Sell |
35,238
-477
| -1% | -$81.7K | 3.31% | 5 |
|
|
2025
Q2 | $5.88M | Buy |
35,715
+254
| +0.7% | +$39K | 3.18% | 5 |
|
|
2025
Q1 | $5.88M | Sell |
35,461
-226
| -0.6% | -$35.4K | 3.32% | 5 |
|
|
2024
Q4 | $5.16M | Buy |
35,687
+932
| +3% | +$144K | 3.05% | 5 |
|
|
2024
Q3 | $5.63M | Sell |
34,755
-266
| -0.8% | -$42.4K | 3.33% | 6 |
|
|
2024
Q2 | $5.12M | Buy |
35,021
+449
| +1% | +$66.8K | 3.29% | 7 |
|
|
2024
Q1 | $5.47M | Buy |
34,572
+13
| +0% | +$2.07K | 3.51% | 6 |
|
|
2023
Q4 | $5.42M | Sell |
34,559
-328
| -0.9% | -$50.3K | 3.72% | 3 |
|
|
2023
Q3 | $5.43M | Sell |
34,887
-794
| -2% | -$131K | 4.1% | 3 |
|
|
2023
Q2 | $5.91M | Sell |
35,681
-75
| -0.2% | -$12.1K | 4.16% | 2 |
|
|
2023
Q1 | $5.54M | Buy |
35,756
+3,071
| +9% | +$496K | 3.98% | 3 |
|
|
2022
Q4 | $5.77M | Buy |
32,685
+249
| +0.8% | +$43K | 4.22% | 1 |
|
|
2022
Q3 | $5.3M | Buy |
32,436
+2,495
| +8% | +$422K | 4.29% | 1 |
|
|
2022
Q2 | $5.32M | Sell |
29,941
-195
| -0.6% | -$34.7K | 3.83% | 3 |
|
|
2022
Q1 | $5.34M | Buy |
30,136
+325
| +1% | +$55.3K | 3.28% | 4 |
|
|
2021
Q4 | $5.1M | Sell |
29,811
-233
| -0.8% | -$38.1K | 2.99% | 5 |
|
|
2021
Q3 | $4.85M | Buy |
30,044
+150
| +0.5% | +$25.6K | 3.17% | 3 |
|
|
2021
Q2 | $4.92M | Buy |
29,894
+44
| +0.1% | +$7.28K | 3.14% | 4 |
|
|
2021
Q1 | $4.91M | Buy |
29,850
+628
| +2% | +$102K | 3.32% | 3 |
|
|
2020
Q4 | $4.6M | Sell |
29,222
-85
| -0.3% | -$12.5K | 3.56% | 3 |
|
|
2020
Q3 | $4.36M | Buy |
29,307
+544
| +2% | +$80.5K | 3.76% | 3 |
|
|
2020
Q2 | $4.04M | Sell |
28,763
-2,565
| -8% | -$374K | 3.79% | 4 |
|
|
2020
Q1 | $4.11M | Sell |
31,328
-495
| -2% | -$70.2K | 4.36% | 3 |
|
|
2019
Q4 | $4.64M | Sell |
31,823
-125
| -0.4% | -$17K | 3.68% | 3 |
|
|
2019
Q3 | $4.13M | Buy |
31,948
+771
| +2% | +$102K | 3.49% | 3 |
|
|
2019
Q2 | $4.34M | Sell |
31,177
-210
| -0.7% | -$29.1K | 3.73% | 3 |
|
|
2019
Q1 | $4.39M | Hold |
31,387
| – | – | 4% | 2 |
|
|
2018
Q4 | $4.05M | Buy |
+31,387
| New | +$4.38M | 4.08% | 2 |
|
Other funds holding JNJ
Brooks Moore & Associates's JNJ Position: Q2 2026 in Review
Brooks Moore & Associates increased its Johnson & Johnson (JNJ) stake by 8.1% in Q2 2026, buying an estimated $604K and bringing the position to 34,417 shares worth $8.74M. The position accounts for 3.92% of the portfolio, ranked #2.
Brooks Moore & Associates first reported a position in JNJ in Q4 2018 and has held it in 31 quarters since. 4,685 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Brooks Moore & Associates held 34,417 shares of Johnson & Johnson worth $8.74M as of Q2 2026.
- Brooks Moore & Associates bought 2,591 Johnson & Johnson shares in Q2 2026, an estimated $604K.
- Johnson & Johnson made up 3.92% of Brooks Moore & Associates's portfolio in Q2 2026, its #2 holding.
- Brooks Moore & Associates first reported a position in Johnson & Johnson in Q4 2018 and has held it in 31 quarters since.
- 4,685 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Brooks Moore & Associates's 13F filing for Q2 2026, filed 17 Aug 2026.